lactulose has been researched along with Hypertension, Portal in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Nikirk, S; Ospina, E; Salim, N; Tapper, EB | 1 |
| Eder, MD; Hosseini, R; Kravetz, JD; Thomas, A; Varma, P | 1 |
| Dhaliwal, G; Geha, RM; Manesh, R; Peters, MG | 1 |
| Alsahhar, JS; Rahimi, RS | 1 |
| Borkar, VV; Kumari, N; Poddar, U; Roy, R; Singh, S; Yachha, SK | 1 |
| Afifi, O; Bakry, A; El-Karaksy, HM; Kader, AA; Saber, N | 1 |
| Carbonara, V; Cariello, R; Cartenì, M; Del Vecchio Blanco, C; Esposito, P; Federico, A; Loguercio, C; Martorelli, L; Miranda, A; Palasciano, G; Portincasa, P; Sapone, A; Scialdone, VR; Tiso, A; Tuccillo, C | 1 |
| Sarin, SK; Sharma, BC; Sharma, P | 1 |
| Ferlitsch, A; Hayden, H; Heinisch, BB; Lammert, F; Mandorfer, M; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Trauner, M; Vogelsang, H | 1 |
| Godai, K; Munemura, C; Murawaki, Y; Noguchi, K; Uemasu, J; Yamamoto, S | 1 |
| Cho, KJ; Moustafa, T; Semiz-Oysu, A | 1 |
| Hao, Z; Lin, N; Ling, YB; Tang, ZF; Xu, RY | 1 |
| Carmassi, F; De Giorgi, A; De Negri, F; Giannarelli, C | 1 |
| Schomerus, H; Schreiegg, J | 1 |
| Dölle, W | 1 |
| Fischer, R; Müting, D; Ordnung, W | 1 |
| Haerting, J; Mantel, E; Nilius, R; Rink, C | 1 |
| Fischer, JE | 1 |
| Müting, D | 1 |
4 review(s) available for lactulose and Hypertension, Portal
| Article | Year |
|---|---|
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc | 2019 |
[Internal therapy of portal hypertension].
Topics: Anti-Bacterial Agents; Ascites; Bed Rest; Cathartics; Dietary Proteins; Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Hypersplenism; Hypertension, Portal; Hypokalemia; Lactulose; Life Expectancy; Water-Electrolyte Balance | 1976 |
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease | 1974 |
[Dietary problems in the treatment of portal hypertension with special reference to portacaval shunt].
Topics: Adult; Ammonia; Animals; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Milk; Phenols; Portacaval Shunt, Surgical; Postoperative Care; Potassium; Sodium; Vitamins | 1974 |
3 trial(s) available for lactulose and Hypertension, Portal
| Article | Year |
|---|---|
Lactulose therapy for patients with cirrhosis, portal hypertension, and poor patient-reported outcomes: The Mi-Kristal trial.
Topics: Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Middle Aged; Patient Reported Outcome Measures; Quality of Life; Treatment Outcome | 2023 |
Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Chronic Disease; Drug Resistance; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hypertension, Portal; Hyponatremia; Lactulose; Leukocyte Count; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Young Adult | 2010 |
Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery.
Topics: Adult; Atrophy; C-Reactive Protein; Cell Membrane Permeability; Drug Therapy, Combination; Female; Glutamine; Human Growth Hormone; Humans; Hypertension, Portal; Immunoglobulins; Interleukin-2; Intestinal Absorption; Intestinal Mucosa; Lactulose; Male; Mannitol; Middle Aged; Proliferating Cell Nuclear Antigen; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2007 |
12 other study(ies) available for lactulose and Hypertension, Portal
| Article | Year |
|---|---|
A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis.
Topics: Aged; Brain; Confusion; Dyskinesias; Esophageal and Gastric Varices; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Hyperbilirubinemia; Hypertension, Portal; Lactulose; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Non-alcoholic Fatty Liver Disease; Renal Veins; Rifaximin; Splenic Vein; Thrombocytopenia; Tomography, X-Ray Computed; Tremor; Vascular Diseases | 2020 |
A Tough Egg to Crack.
Topics: Aged; Anti-Bacterial Agents; Consciousness Disorders; Diagnosis, Differential; Female; Humans; Hypertension, Portal; Lactulose; Rifaximin | 2018 |
Duodenal morphometry and small bowel permeability in children with portal hypertension.
Topics: Adolescent; Biopsy; Body Height; Body Weight; Case-Control Studies; Child; Constriction, Pathologic; Dietary Proteins; Duodenal Diseases; Duodenum; Energy Intake; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Mannitol; Nutritional Status; Permeability; Portal Vein; Prospective Studies; Skinfold Thickness; Vascular Diseases; Young Adult | 2015 |
A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.
Topics: Chi-Square Distribution; Child; Cohort Studies; Egypt; Electroencephalography; Female; Follow-Up Studies; Hepatic Encephalopathy; Hepatic Veno-Occlusive Disease; Hospitals, University; Humans; Hypertension, Portal; Lactulose; Liver Function Tests; Male; Neuropsychological Tests; Pilot Projects; Prospective Studies; Psychometrics; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2017 |
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
Topics: Adult; Age Factors; Aged; Alcoholism; Case-Control Studies; Diabetes Complications; Female; Hepatitis, Chronic; Humans; Hypertension, Portal; Interleukin-6; Intestinal Absorption; Lactulose; Liver Cirrhosis; Male; Mannitol; Middle Aged; Nitrites; S-Nitrosothiols; Tumor Necrosis Factor-alpha | 2010 |
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
Topics: Acute-Phase Proteins; Adrenergic beta-Antagonists; Adult; Aged; Bacterial Translocation; Carrier Proteins; Cell Membrane Permeability; Comorbidity; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Interleukin-6; Intestinal Absorption; Kaplan-Meier Estimate; Lactulose; Liver Cirrhosis; Male; Mannitol; Membrane Glycoproteins; Middle Aged; Sucrose | 2013 |
[Case of autosomal dominant polycystic kidney disease presenting hepatic encephalopathy].
Topics: Aged; Cysts; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Diseases; Polycystic Kidney, Autosomal Dominant; Renal Dialysis; Renal Veins; Splenic Vein | 2005 |
Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension.
Topics: Aged; Aortic Valve Stenosis; Cardiac Tamponade; Cardiopulmonary Bypass; Coronary Artery Disease; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Hemorrhage | 2007 |
Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diet, Sodium-Restricted; Diuretics; Drug Therapy, Combination; Dyspnea; Edema; Female; Fibrinolytic Agents; Gastrointestinal Agents; Heparin, Low-Molecular-Weight; Humans; Hypertension, Portal; Hypertension, Pulmonary; Lactulose; Liver Cirrhosis; Portal Pressure; Portasystemic Shunt, Surgical; Spironolactone; Treatment Outcome; Vasodilator Agents; Venous Thrombosis | 2007 |
Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice.
Topics: Adult; Aged; Cross-Sectional Studies; Drug Monitoring; Family Practice; Female; Germany; Hepatic Encephalopathy; Humans; Hypertension, Portal; Incidence; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Psychometrics | 1993 |
[Portal hypertension from the internal medicine viewpoint].
Topics: Furosemide; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Spironolactone; Vasopressins | 1976 |
[Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis].
Topics: Aged; Ammonia; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Tremor | 1985 |